These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33254251)

  • 1. [Therapeutic drug monitoring of antiinfectives in intensive care unit patients - what's new?].
    König C; Kluge S; Wicha SG
    Dtsch Med Wochenschr; 2020 Dec; 145(24):1764-1769. PubMed ID: 33254251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of anti-infective agents in critically ill patients.
    Jager NG; van Hest RM; Lipman J; Taccone FS; Roberts JA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):961-79. PubMed ID: 27018631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of commonly used anti-infective agents: A nationwide cross-sectional survey of Australian hospital practices.
    Imani S; Alffenaar JW; Cotta MO; Daveson K; van Hal S; Lau C; Marriott D; Penm J; Roberts JA; Tabah A; Trethewy N; Williams P; Sandaradura I
    Int J Antimicrob Agents; 2020 Dec; 56(6):106180. PubMed ID: 32987102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for Antibiotics.
    Wicha SG; Märtson AG; Nielsen EI; Koch BCP; Friberg LE; Alffenaar JW; Minichmayr IK;
    Clin Pharmacol Ther; 2021 Apr; 109(4):928-941. PubMed ID: 33565627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
    Muller AE; Huttner B; Huttner A
    Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic drug monitoring and pharmacokinetic models as a strategy for rational antibiotic therapy in intensive care patients].
    Schatz LM; Zoller M; Scharf C; Liebchen U
    Anaesthesiologie; 2022 Jul; 71(7):495-501. PubMed ID: 35925054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
    Williams P; Cotta MO; Roberts JA
    Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
    Sadilová K; Halačová M; Černý D
    Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in clinical antibiotic testing.
    Rentsch KM
    Adv Clin Chem; 2022; 110():73-116. PubMed ID: 36210077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising antimicrobial therapy through the use of Bayesian dosing programs.
    Avent ML; Rogers BA
    Int J Clin Pharm; 2019 Oct; 41(5):1121-1130. PubMed ID: 31392582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation.
    Sandaradura I; Alffenaar JW; Cotta MO; Daveson K; Day RO; Van Hal S; Lau C; Marriott DJE; Penm J; Roberts JA; Tabah A; Williams P; Imani S
    Br J Clin Pharmacol; 2022 Feb; 88(2):669-679. PubMed ID: 34289135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole: an audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package.
    Chaudhri K; Stocker SL; Williams KM; McLeay RC; Marriott DJE; Di Tanna GL; Day RO; Carland JE
    J Antimicrob Chemother; 2020 Jul; 75(7):1981-1984. PubMed ID: 32277819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic Drug Monitoring of Antimicrobial Agents].
    Kadomura S
    Rinsho Byori; 2016 Dec; 64(12):1367-1372. PubMed ID: 30653900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring: linezolid too?
    Richards GA; Brink AJ
    Crit Care; 2014 Sep; 18(5):525. PubMed ID: 25673559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic Drug Monitoring of antiinfectives in intensive care medicine].
    Nosseir NS; Michels G; Pfister R; Adam R; Wiesen MH; Müller C
    Dtsch Med Wochenschr; 2014 Sep; 139(38):1889-94. PubMed ID: 25203549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
    Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
    Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
    Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.